Downregulated lncRNA SNHG18 Suppresses the Progression of Hepatitis B Virus-Associated Hepatocellular Carcinoma and Meditates the Antitumor Effect of Oleanolic Acid

References

• Chen Y, Tian Z. HBV-induced immune imbalance in the development of HCC. Front Immunol. 2019;10:2048. doi:10.3389/fimmu.2019.02048
   PubMed Web of Science ®Google Scholar
• Xie Y. Hepatitis B virus-associated hepatocellular carcinoma. Adv Exp Med Biol. 2017;1018:11–21.
   PubMed Web of Science ®Google Scholar
• Luo P, Wu S, Yu Y, et al. Current status and perspective biomarkers in AFP negative HCC: towards screening for and diagnosing hepatocellular carcinoma at an earlier stage. Pathol Oncol Res. 2020;26(2):599–603. doi:10.1007/s12253-019-00585-5
   PubMed Web of Science ®Google Scholar
• Wang W, Wei C. Advances in the early diagnosis of hepatocellular carcinoma. Genes Dis. 2020;7(3):308–319. doi:10.1016/j.gendis.2020.01.014
   PubMed Web of Science ®Google Scholar
• Pollier J, Goossens A. Oleanolic acid. Phytochemistry. 2012;77:10–15. doi:10.1016/j.phytochem.2011.12.022
   PubMed Web of Science ®Google Scholar
• Zhou R, Zhang Z, Zhao L, et al. Inhibition of mTOR signaling by oleanolic acid contributes to its anti-tumor activity in osteosarcoma cells. J Orthop Res. 2011;29(6):846–852. doi:10.1002/jor.21311
   PubMed Web of Science ®Google Scholar
• Wang H, Zhong W, Zhao J, et al. Oleanolic acid inhibits epithelial-mesenchymal transition of hepatocellular carcinoma by promoting iNOS dimerization. Mol Cancer Ther. 2019;18(1):62–74. doi:10.1158/1535-7163.MCT-18-0448
   PubMed Web of Science ®Google Scholar
• Zhou W, Zeng X, Wu X. Effect of oleanolic acid on apoptosis and autophagy of SMMC-7721 hepatoma cells. Med Sci Monit. 2020;26:e921606. doi:10.12659/MSM.921606
   PubMed Web of Science ®Google Scholar
• Chaturvedi VK, Singh A, Dubey SK, Hetta HF, John J, Singh MP. Molecular mechanistic insight of hepatitis B virus mediated hepatocellular carcinoma. Microb Pathog. 2019;128:184–194. doi:10.1016/j.micpath.2019.01.004
   PubMed Web of Science ®Google Scholar
• Zhao X, Liu M, Li D. Oleanolic acid suppresses the proliferation of lung carcinoma cells by miR-122/Cyclin G1/MEF2D axis. Mol Cell Biochem. 2015;400(1–2):1–7. doi:10.1007/s11010-014-2228-7
   PubMed Web of Science ®Google Scholar
• Han D, Zhang X, Zhang J, et al. Oleanolic acid suppresses vascular smooth muscle cell proliferation by increasing lincRNA-p21 expression. Oncol Lett. 2016;12(5):3519–3522. doi:10.3892/ol.2016.5096
   PubMed Web of Science ®Google Scholar
• Liu XF, Thin KZ, Ming XL, et al. Small nucleolar RNA host gene 18 acts as a tumor suppressor and a diagnostic indicator in hepatocellular carcinoma. Technol Cancer Res Treat. 2018;17:1533033818794494. doi:10.1177/1533033818794494
   Web of Science ®Google Scholar
• Huang LJ, Shen Y, Bai J, et al. High expression levels of long noncoding RNA small nucleolar RNA host gene 18 and semaphorin 5A indicate poor prognosis in multiple myeloma. Acta Haematol. 2020;143(3):279–288. doi:10.1159/000502404
   PubMed Web of Science ®Google Scholar
• Zheng R, Yao Q, Ren C, et al. Upregulation of long noncoding RNA small nucleolar RNA host gene 18 promotes radioresistance of glioma by repressing semaphorin 5A. Int J Radiat Oncol Biol Phys. 2016;96(4):877–887. doi:10.1016/j.ijrobp.2016.07.036
   PubMed Web of Science ®Google Scholar
• Bao Y, Zhang S, Chen Z, et al. Synergistic chemotherapy for breast cancer and breast cancer brain metastases via paclitaxel-loaded oleanolic acid nanoparticles. Mol Pharm. 2020;17(4):1343–1351. doi:10.1021/acs.molpharmaceut.0c00044
   PubMedGoogle Scholar
• Niu G, Sun L, Pei Y, Wang D. Oleanolic acid inhibits colorectal cancer angiogenesis by blocking the VEGFR2 signaling pathway. Anticancer Agents Med Chem. 2018;18(4):583–590. doi:10.2174/1871520617666171020124916
   PubMed Web of Science ®Google Scholar
• Shopit A, Li X, Tang Z, et al. miR-421 up-regulation by the oleanolic acid derivative K73-03 regulates epigenetically SPINK1 transcription in pancreatic cancer cells leading to metabolic changes and enhanced apoptosis. Pharmacol Res. 2020;161:105130. doi:10.1016/j.phrs.2020.105130
   PubMed Web of Science ®Google Scholar
• Liu J, Zheng L, Zhong J, Wu N, Liu G, Lin X. Oleanolic acid induces protective autophagy in cancer cells through the JNK and mTOR pathways. Oncol Rep. 2014;32(2):567–572. doi:10.3892/or.2014.3239
   PubMed Web of Science ®Google Scholar
• Li YW, Yang FC, Lu HQ, Zhang JS. Hepatocellular carcinoma and hepatitis B surface protein. World J Gastroenterol. 2016;22(6):1943–1952. doi:10.3748/wjg.v22.i6.1943
   PubMed Web of Science ®Google Scholar
• Tong S, Revill P. Overview of hepatitis B viral replication and genetic variability. J Hepatol. 2016;64(1 Suppl):S4–S16. doi:10.1016/j.jhep.2016.01.027
   PubMed Web of Science ®Google Scholar
• Feng J, Yang G, Liu Y, et al. LncRNA PCNAP1 modulates hepatitis B virus replication and enhances tumor growth of liver cancer. Theranostics. 2019;9(18):5227–5245. doi:10.7150/thno.34273
   PubMed Web of Science ®Google Scholar
• Zheng R, Yao Q, Li X, Xu B. Long noncoding ribonucleic acid SNHG18 promotes glioma cell motility via disruption of alpha-enolase nucleocytoplasmic transport. Front Genet. 2019;10:1140. doi:10.3389/fgene.2019.01140
   PubMed Web of Science ®Google Scholar
• Fattovich G, Stroffolini T, Zagni I, Donato F. Hepatocellular carcinoma in cirrhosis: incidence and risk factors. Gastroenterology. 2004;127(5 Suppl 1):S35–S50. doi:10.1053/j.gastro.2004.09.014
   PubMed Web of Science ®Google Scholar
• Kanda T, Goto T, Hirotsu Y, Moriyama M, Omata M. Molecular mechanisms driving progression of liver cirrhosis towards hepatocellular carcinoma in chronic hepatitis B and C infections: a review. Int J Mol Sci. 2019;20(6):1358. doi:10.3390/ijms20061358
   PubMed Web of Science ®Google Scholar
• Daoud A, Teeter L, Ghobrial RM, et al. Transplantation for hepatocellular carcinoma: is there a tumor size limit? Transplant Proc. 2018;50(10):3577–3581. doi:10.1016/j.transproceed.2018.04.038
   PubMed Web of Science ®Google Scholar
• Huang WJ, Jeng YM, Lai HS, Sheu FY, Lai PL, Yuan RH. Tumor size is a major determinant of prognosis of resected stage I hepatocellular carcinoma. Langenbecks Arch Surg. 2015;400(6):725–734. doi:10.1007/s00423-015-1329-4
   PubMed Web of Science ®Google Scholar
• Kim SJ, Lee KK, Kim DG. Tumor size predicts the biological behavior and influence of operative modalities in hepatocellular carcinoma. Hepato-gastroenterology. 2010;57(97):121–126.
   PubMedGoogle Scholar
• Liu M, Yan Q, Sun Y, et al. A hepatocyte differentiation model reveals two subtypes of liver cancer with different oncofetal properties and therapeutic targets. Proc Natl Acad Sci U S A. 2020;117(11):6103–6113. doi:10.1073/pnas.1912146117
   PubMed Web of Science ®Google Scholar
• Zhang W, Mu D, Feng K. Hierarchical potential differentiation of liver cancer stem cells. Adv Clin Exp Med. 2017;26(7):1137–1141. doi:10.17219/acem/66343
   PubMed Web of Science ®Google Scholar